Taiwan Industry Reports
Industry Type:   Title:  

Raw Material Medicine Manufacturing
2019-AugDoc #31280Industry Report (condensed version)US$100
The benefits of vertical integration are gradually becoming apparent, and firms within the industry continue to enter the emerging markets through niche products. Consequently, the industry is expected to witness a slight increase in sales in the third quarter of 2019.
Food Biotechnology Industry
2019-AprDoc #30670Industry Report (condensed version)US$100
Both output and sales of the industry are expected to maintain a steady growth, while demand for functional beverages and dietary supplements will remain strong in China, prompting major industry participants to be active in expanding the production lines.
Food Biotechnology Industry
2018-JunDoc #29121Industry Report (condensed version)US$100
Boosted by a sharp increase in demand for dietary Supplement in China, Taiwanese firms, Grape King Inc. and TCI Bio Corporation Limited Corporation Limited continue to develop plans to build factories and explore the China market.
Regenerative Medicine
2017-MarDoc #27026Industry Report (condensed version)US$75
Although the industry is expected to see a slight growth in output value, ranging from 3 percent to 5 percent, the industry is still in its embryonic stage.
Food Biotechnology Industry
2016-DecDoc #26450Industry Report (condensed version)US$75
China’s nutritional food improves and will contribute to a steady growth in the production value of Taiwan’s food biotechnology industry in 2017.
Regenerative Medicine Industry
2016-JunDoc #25563Industry Report (condensed version)US$75
The industry’s output value is expected to rise marginally by 3 – 5 percent year-on-year in the first half of 2016.
Agricultural Biotechnology Industry
2016-JanDoc #24872Industry Report (condensed version)US$75
In the first ten months of 2015, Taiwan’s exports of bottle orchid seedlings fell by 4.53 percent in value because of China’s ban on imports. However, other animal vaccines enjoyed a strong growth, and Taiwan’s effort to support the agricultural biotechnology industry lifted other animal vaccines industry.
Regenerative Medicine
2015-OctDoc #24378Industry Report (condensed version)US$75
Both output and sales values of the industry will still contract in the third quarter of 2015 from the same period a year earlier as a consequence of weaker-than-expected export to China and a decline in the prices of cotton yarn products.
Western Medicines and Biopharmaceuticals
2015-SepDoc #24268Industry Report (condensed version)US$75
The industry sales would rise in value in the final quarter of 2015 from a year earlier, and growth would range between 1 percent and 3 percent.
Raw Material Medicine Manufacturing
2015-AugDoc #24137Industry Report (condensed version)US$75
Despite poor domestic sales of the industry, firms within the industry continue to launch new products. Additionally, customers in Europe, India, and Japan keep restocking, suggesting the industry’s sales growth would range between 2 percent and 4 percent in the second half of 2015.
 First  Previous  Next  Last  In  1  /  4  Page  (Find  35  records)

Copyright (c) 2018 All Rights Reserved by
Taiwan Institute of Economic Research
Taiwan Industry Economics Services
Address: 4Fl., 16-8, Tehui St., Taipei, Taiwan
TEL: 886-2-25865000 ext469; FAX: 886-2-25935543